Abstract
Intraarterial infusion of cis-platinum was evaluated in 14 patients with primary osteosarcoma because the method delivers a higher dose to the neoplasm without increasing systemic toxicity. The tumor response was evaluated by clinical examination, conventional radiography, angiography, and histopathologic examination. Eight (57%) of the 14 patients responded. Among the eight responders, four patients with medullary osteosarcoma of the extremities were treated by limb salvage operation followed by insertion of an endoprosthesis to preserve limb function. The responders are all alive with a median follow-up period of 17.5 months; six of them have no evaluable disease. The six failures died of disease after median survival of 6.5 months. Intraarterial cis-platinum infusion proved to be an effective approach in treating osteosarcoma and created the opportunity for limb salvage.
Similar content being viewed by others
References
Baum E, Greenberg L, Gaynon P, Krivit W, Hammond D (1978) Use of cis-platinum diammine dichloroplatinum (CDDP) in osteogenic sarcoma (OS) in children (Abstract C-315) Proc Am Assoc Cancer Res Am Soc Clin Oncol 19:385
Calvo DB, Patt YZ, Wallace S, Hersh EM, Benjamin RS, Prichard J, Mavligit GM (1979) Phase I trial of percutaneous intra-arterial (IA) Cis-diammine Dichloride Platinum (II) (CDDP) for regionally confined malignancies (Abstract C-558). Proc Am Assoc Cancer Res Am Soc Clin Oncol 20:426
Cortex EP, Holland JF, Glidewell O (1978) Amputation and adriamycin in primary osteosarcoma: A 5-year report. Cancer Treat Rep 62:279–282
De Santos LA, Murray JA, Ayala AG (1979) The value of percutaneous needle biopsy in the management of primary bone tumors. Cancer 43:735–744
Eagan RT, Fleming TR, Schoonover V (1979) Evaluation of response criteria in advanced lung cancer. Cancer 44:1125–1128
Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, Steele C, Frei E III (1978) A clinical pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2 deoxyuridine and 5-fluorourcil. Cancer Res 38:3784–3792
Gehan EA, Sutow WW, Uribe-Botero G, Romsdahl M, Smith TL (1978) Immunotherapy of cancer: present status of treatment in man. Raven Press, New York
Higby DJ, Wallace HJ, Holland JF (1973) Cis-diamminedi-chloroplatinum (NSC-119875): A phase I study. Cancer Chemother Rep 57:459–463
Ihide DC, Bunn PA, Cohen MH, Dunnick NR, Eddy JL, Minna JD (1980) Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: Methods of documenting tumor response and progression. Cancer 45:1300–1310
Jaffe N, Frei E III, Traggis D, Bishop Y (1974) Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med 291:994–997
Jaffe N, Frei E III, Watts H, Traggis D (1978) High-dose methotrexate in osteogenic sarcoma: A 5-year experience. Cancer Treat Rep 62:259–264
Jaffe N, Watts H, Fellows KE, Vanter G (1978) Local en bloc resection for limb preservation. Cancer Treat Rep 62:217–223
Marcove RC, Mike V, Hajek JV, Levin AC, Hutter RVP (1970) Osteogenic sarcoma under the age of twenty-one: A review of 145 operative cases. J Bone Joint Surg 52:411–423
Nitschke R, Starling KA, Vats T, Bryan H (1978) Cis-diamminedichloroplatinum (NSC 119875) in childhood malignancies: A Southwest Oncology Group study. Med Pediatr Oncol 4:127–132
Ochs J, Freeman AJ, Douglas HO, Higby DS, Mindell ER, Sinks LF (1978) Cis-dichlorodiammine-platinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep 62:239–245
Pratt CB, Hayes FA, Green AA, Evans WE, Senzer N, Howarth C, Ransom JL (1979) Phase II pharmacokinetic study of cis-platinum diamminedichloride (CPDD) in children with solid tumors (Abstract C-290) Proc Am Assoc Cancer Res Am Soc Clin Oncol 20:361
Pritchard JD, Mavligit GM, Benjamin RS, Patt YZ, Calvo D, Hall SW, Bodey GP, Wallace S (1979) Regression of regionally confined melanoma with intra-arterial cis-dichlorodiammine-platinum (II). Cancer Treat Rep 63:555–558
Pritchard JD, Mavligit GM, Wallace S, Benjamin RS, McBride CM (1979) Regression of regionally advanced malignant melanoma after arterial infusion with cis-platinum and actinomucin-D. Clin Oncol 5:179–182
Rosen G, Nirenberg A, Juergens H, Tan C (1979) Phase II trial of cis-platinum in osteogenic sarcoma (Abstract C-299). Proc Am Assoc Cancer Res Am Soc Clin Oncol 20:363
Rosen G, Suwansirikul S, Kwon C, Tan C, Wu SJ, Bettie EJ, Jr, Murphy ML (1974) High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer 33:1151–1163
Rosen G, Murphy ML, Hovos AG, Gutierrez M, Marcove RC (1976) Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37:1–11
Rosenberg B, Van Camp L, Krigas T (1965) Inhibition of cell division ofEscherichia coli by electrolysis produced from a platinum electrode. Nature 205:698–699
Rozencweig M, Von Hoff D, Penta J, Muggia FM (1977) Clinical status cis-diamminedichloroplatinum (II). J Clin Hematol Oncol 7:672–680
Rozencweig M, Von Hoff DD, Slavik M, Muggia FM (1977) Cis-diamminedichloroplatinum (II): A new anticancer drug. Ann Intern Med 8:803–812
Samson MK, Baker LH, Benjamin RS, Lane M (1979) Cis-diamminedichloroplatinum (II) (NSC 119875) in advanced soft tissue and bony sarcomas: A Southwest Oncology Group Study. Cancer Treat Rep 63:2027–2029
Stewart DJ, Benjamin RS, Siefert W, Wallace S, Gutterman JU, Patt YZ, Calvo DB, Samuels M, Loo TL (1980) Clinical pharmacology of intraarterial cis-diamminedichloroplatinum (II) (Abstract C-76) Proc Am Assoc Cancer Res Am Soc Clin Oncol 21:337
Sutow WW (1978) Primary adjuvant chemotherapy in osteosarcoma. Cancer Bulletin 30:178–181
Sutow WW (1976) Late metastases in osteosarcoma. Lancet 1:856
Sutow WW, Gehan EA, Dyment PG, Vietti T, Miale T (1978) Multidrug adjuvant chemotherapy for osteosarcoma: Interim report of the Southwest Oncology Group studies. Cancer Treat Rep 62:265–269
Sutow WW, Gehan EA, Vietti TJ, Frias AE, Dyment PG (1976) Multidrug chemotherapy in primary treatment of osteosarcoma. J Bone Joint Surg 58A:629–633
Taylor WF, Ivins JC, Dahlin DC (1978) Osteogenic sarcoma experience at the Mayo Clinic. Immunotherapy of cancer: Present status of treatment in man. Raven Press, New York
Witshaw E (1977) In discussion of clinical trial trials of cis-platinum diamminedichloride (by I Krakoff). J Clin Hematol Oncol 7:604–618
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chuang, V.P., Wallace, S., Benjamin, R.S. et al. The therapy of osteosarcoma by intraarterial cis-platinum and limb preservation. Cardiovasc Intervent Radiol 4, 229–235 (1981). https://doi.org/10.1007/BF02552525
Issue Date:
DOI: https://doi.org/10.1007/BF02552525